V006-1911 Screening compound: N-{2-[5-(4-chlorophenyl)-3-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl]-2-oxoethyl}-N-methylcyclopentanecarboxamide

V006-1911 Screening compound: N-{2-[5-(4-chlorophenyl)-3-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl]-2-oxoethyl}-N-methylcyclopentanecarboxamide
V006-1911 Screening compound: N-{2-[5-(4-chlorophenyl)-3-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl]-2-oxoethyl}-N-methylcyclopentanecarboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V006-1911
N-{2-[5-(4-chlorophenyl)-3-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl]-2-oxoethyl}-N-methylcyclopentanecarboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V006-1911

Molecular Formula

C25H28ClN3O3 (C25 H28 ClN3 O3)

Compound Name

N-{2-[5-(4-chlorophenyl)-3-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl]-2-oxoethyl}-N-methylcyclopentanecarboxamide

IUPAC name

N-{2-[5-(4-chlorophenyl)-3-(4-methoxyphenyl)-45-dihydro-1H-pyrazol-1-yl]-2-oxoethyl}-N-methylcyclopentanecarboxamide

SMILES

CN(CC(N(C(C1)c(cc2)ccc2Cl)N=C1c(cc1)ccc1OC)=O)C(C1CCCC1)=O

InChI

InChI=1S/C25H28ClN3O3/c1-28(25(31)19-5-3-4-6-19)16-24(30)29-23(18-7-11-20(26)12-8-18)15-22(27-29)17-9-13-21(32-2)14-10-17/h7-14,19,23H,3-6,15-16H2,1-2H3/t23-/m0/s1

InChI Key

YXBHBPLMXZEFQI-QHCPKHFHSA-N

MDL Number (MFCD)

MFCD19807952

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

453.97

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.944

Distribution Coefficient, logD

4.944

Water Solubility, LogSw

-5.28

Polar Surface Area

51.111

Acid Dissociation Constant (pKa)

18.65

Base Dissociation Constant (pKb)

1.10

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

40.00

V006-1911 in Drug Discovery

Included in Screening Libraries

Anti-infective Library (19449 compounds)

Aurora A-B Kinases Targeted Library (9426 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Immune system
  • animal
  • Cancer
  • Digestive system
  • Male
  • Female
  • Hemic and lymphatic
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with V006-1911 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V006-1911?
Check Price and Availability of V006-1911, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V006-1911 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V006-1911
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V006-1911
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V006-1911 available by request